MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.47 -0.23 (-1.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Liabilities and Shareholders Equity (2020 - 2026)

Updated

MoonLake Immunotherapeutics (MLTX) reported Liabilities and Shareholders Equity of $573.95 million for Q2 2026, up 24.7% from $460.1 million a year earlier and up 43.4% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, MoonLake Immunotherapeutics posted Liabilities and Shareholders Equity of $424.43 million, down 11.2% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 29.5% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $477.93 million in FY2024 (-9.2%), $526.54 million in FY2023 (+585.2%), $76.84 million in FY2022 (+693.6%) and $9.68 million in FY2021 (-91.7%).
  • The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2020.
  • Year over year, Liabilities and Shareholders Equity gained in two of the last eight quarters, with an average decline of 7.3%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q1 2024 (growth of 744.5%); the low point was Q4 2021 (a decline of 91.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $400.37 million (Q1 2026), $424.43 million (Q4 2025) and $414.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - 573.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 573.95 Mn
Mar 31, 2026 400.37 Mn
Dec 31, 2025 424.43 Mn
Sep 30, 2025 414.34 Mn
Jun 30, 2025 460.10 Mn
Mar 31, 2025 511.26 Mn
Dec 31, 2024 477.93 Mn
Sep 30, 2024 518.21 Mn
Jun 30, 2024 544.88 Mn
Mar 31, 2024 564.12 Mn
Dec 31, 2023 526.54 Mn
Sep 30, 2023 500.22 Mn
Jun 30, 2023 506.62 Mn
Mar 31, 2023 66.80 Mn
Dec 31, 2022 76.84 Mn
Sep 30, 2022 88.59 Mn
Jun 30, 2022 98.43 Mn
Mar 31, 2022 231.21 Mn
Dec 31, 2021 9.68 Mn
Sep 30, 2021 116.25 Mn
API Access

MoonLake Immunotherapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MLTX&period=max&api_key=YOUR_API_KEY